| HIV Infection |
1 |
1 |
| Anal Cancer |
0 |
0.93 |
| Colorectal Cancer |
0 |
0.73 |
| Cancer |
0 |
0.68 |
| Anus |
0 |
0.58 |
| Biologic Therapy |
0 |
0.51 |
| Cervical Cancer |
0 |
0.5 |
| Preventive Screening |
0 |
0.15 |
| Social Determinants of Health |
0 |
0.13 |
| Viral Load |
0 |
0.1 |
| Revenue and Practice Management |
0 |
0.08 |
| AIDS |
0 |
0.07 |
| Anoscopy |
0 |
0.07 |
| Biopsy |
0 |
0.07 |
| Pap Smear |
0 |
0.07 |
| Blood |
0 |
0.05 |
| CD4 |
0 |
0.05 |
| Insurance |
0 |
0.05 |
| Primary Care |
0 |
0.05 |
| Transgender |
0 |
0.05 |
| Crohn Disease |
0 |
0.04 |
| Intimate Partner Violence |
0 |
0.04 |
| Tobacco Cessation |
0 |
0.04 |
| Treatment Guidelines |
0 |
0.04 |
| Ulcerative Colitis |
0 |
0.04 |
| Ablation |
0 |
0.03 |
| Abuse |
0 |
0.03 |
| Anxiety |
0 |
0.03 |
| Anxiety Disorder |
0 |
0.03 |
| Biomarker |
0 |
0.03 |
| Biomedical Technology |
0 |
0.03 |
| Board Certification |
0 |
0.03 |
| California |
0 |
0.03 |
| Clinical Guidelines |
0 |
0.03 |
| Coagulation |
0 |
0.03 |
| Colitis |
0 |
0.03 |
| Depression |
0 |
0.03 |
| Epidemic |
0 |
0.03 |
| Epidemiology |
0 |
0.03 |
| Financial Reimbursement |
0 |
0.03 |
| Georgia |
0 |
0.03 |
| Immunocompromise |
0 |
0.03 |
| Inflammatory Bowel Disease |
0 |
0.03 |
| LGBT |
0 |
0.03 |
| Lupus |
0 |
0.03 |
| Medicaid |
0 |
0.03 |
| Opportunistic Infection |
0 |
0.03 |
| Orbit |
0 |
0.03 |
| Sexual Health |
0 |
0.03 |
| Smoking |
0 |
0.03 |
| Uninsured |
0 |
0.03 |
| Violence |
0 |
0.03 |